Navigation Links
GenScript kündigt gemeinsame Roadshow mit Open Monoclonal Technology, Inc. an
Date:1/22/2013

PISCATAWAY, New Jersey, 22. Januar 2013 /PRNewswire/ -- GenScript und Open Monoclonal Technology, Inc. (OMT) kündigten heute eine gemeinsame Roadshow mit potenziellen Kunden aus den Vereinigten Staaten, China, Japan und Südkorea an, die Ende Januar und Anfang Februar stattfinden soll. Die Roadshow wird möglichen Neukunden eine Einführung in die Technologien zur Identifizierung humaner Antikörper von GenScript und OMT bieten und zu einer beschleunigten und verbesserten Entwicklung dieser wichtigen Humantherapeutika-Klasse führen.

GenScript

GenScript deckt das volle Dienstleistungsspektrum humaner Antikörper ab, darunter die Bereiche Target-Screening und -Expression, Immunisierung, das Screening monoklonaler Antikörper jedes gewünschten Komplexitätsgrads, Antikörper-Sequenzierung und -Charakterisierung, biologische und sonstige Assays, Antikörperproduktion und Zelllinienentwicklung, auf Tiermodellen beruhende Effizienzstudien und mehr. Das Antikörper-Entwicklungsteam von GenScript besteht aus ranghohen Wissenschaftlern und Führungskräften aus der Wirtschaft, die über umfassende Erfahrung bei der Entwicklung therapeutischer Antikörper verfügen und in den kompletten Prozess der therapeutischen Wirkstoffentwicklung eingebunden waren. GenScript hat sich im Bereich der Gensynthese eine weltweite Führungsposition erarbeitet und ist auch in vielen weiteren biologischen Dienstleistungsbereichen führend.

Open Monoclonal Technology, Inc.

Open Monoclonal Technology, Inc. (OMT) ist im Bereich der gentechnischen Veränderung von Tieren zur Entwicklung humaner therapeutischer Antikörper – naturally optimized human antibodies™ – führend. OMT hat OmniRat™ erschaffen, die er
'/>"/>

SOURCE GenScript USA Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GenScript anuncia una muestra itinerante conjunta con Open Monoclonal Technology, Inc.
2. GenScript Anuncia Exposição Itinerante Junto com a Open Monoclonal Technology, Inc.
3. Thesan Pharmaceuticals gibt Serie-A-Finanzierung unter gemeinsamer Führung von Novo Ventures und Novartis Venture Funds bekannt
4. Office Star to Launch Safety Campaign at The Mobility Roadshow
5. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
6. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
7. VLST Corporation Announces In-licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody
8. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
9. Ablation Devices Market to 2016 - (Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Cardiac, Cancer and Gynecology) - Global Market Forecast and Trends Analysis by Technology, Devices & Applications
10. Radiotherapy Devices Market By Technology, Applications & Products (2011 - 2016)
11. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its ... highly sophisticated agro-breeding solutions for plant breeders and researchers, ... board of directors appointed chemistry and pharmaceutical industry expert ... of the board. From 1975 to 2012, ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. ... a U.S. provisional patent application concerning composition of matter, ... achieve targeted tumor cell death.  This ... noncoding double stranded RNA molecules (VSRNAs) which interfere with ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... 11, 2011 Tonight,s "Dan Rather Reports" examines ... of antibiotics. Every year, more than 90,000 Americans ... antibiotic-resistant infections, caused directly by the overuse of ... $35 billion a year.  In tonight,s program, Dan ...
... 2011 WebMD Health Corp. (Nasdaq: WBMD ) ... million aggregate principal amount of 2.50% Convertible Notes due 2018 ... the exercise in full of the initial purchaser,s over-allotment option). ... to Rule 144A under the Securities Act of 1933.   ...
Cached Medicine Technology:Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences? 2Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences? 3Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences? 4WebMD Closes Offering of 2.50% Convertible Notes Due 2018 2
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... 2014U.S. military personnel who served in Iraq and ... brain injury (TBI) were compared to military personnel ... reasons. Differences in measures of overall disability, cognitive ... injury are reported in an article in ... Mary Ann Liebert, Inc., publishers. The article is ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... Calif.) An international team led by researchers at ... complex, which plays a key role in cell division, ... This is the first time the complex has been ... make cyclin B1/Cdk1 an excellent target to control cellular ... The research was published online today in the journal ...
(Date:4/17/2014)... not uncommon these days to find a colored ribbon representing ... breast cancer. But what color ribbon does one think of ... designated color, for many suffering from the disease, black may ... University study consisting of lung cancer patients, primarily smokers between ... more light on the stigma often felt by these patients, ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Unraveling the 'black ribbon' around lung cancer 2
... have alerted the public about toxic carrot juice supplied ... Canadians// due to the contamination caused by the botulism ... by Bolthouse Farms, nearly 10 Toronto Businesses continued to ... States nearly four were hospitalized after consuming the juice, ...
... may be governed by her ovaries according to a new ... Claire// showed that women put more time and effort into ... a woman’s clothes and makeup affected at that time of ... men and each other alter as well. ,Study's ...
... dengue fever grips the country, another viral disease chikungunya ... //have been reported across nine states. ,Though Delhi ... worst hit is Karnataka with over 756,028 suspected cases ... ,Maharashtra has 262,595 suspected and 679 confirmed cases. ...
... indeed a wake-up call to the food and drug watchdog, ... in the market. This has been put forth vociferously by ... advisory panel. ,A report enabled by The Institute ... the FDA with more manpower, finance and authority to be ...
... For Health Technologies Inc., makers of IntelliFill i.v.?, ... IV medications in syringes//, announced today that Children’s ... producing over three million syringes using the IntelliFill ... October 2002. The hospital’s inpatient pharmacy is currently ...
... Dr Mukesh Haikerwal, said today the Government must make ... to be truly effective in meeting the needs of ... were announced today by the Prime Minister, and the ... care. ,While the AMA is generally pleased ...
Cached Medicine News:Health News:Women’s Fashion Sense Linked to Her Ovulatio 2Health News:Medical Center Tops 3 Million IV Syringes Using IntelliFill i.v. Robotics 2Health News:Mental Health Package Regrettably Undervalues the Role of the GP 2
... True/Flex Upper Extremity Intramedullary Rod System offers ... to conventional methods of rodding and plating. ... at the fracture site and enhanced healing4 ... to be easily inserted into the canal. ...
Interphlex Flexible Stablization Rods offer correction of Hammer Toes with a High level of Flexibility while maintaining correct toe length and shape....
The True/Fix Compression Hip Screw System offers a wide variety of plate and screw sizes available....
... Simple, cost-effective microfiltration for your transfusion ... also brings you an easy and ... of microfiltration for a variety of ... postoperative applications, autologous or homologous transfusions, ...
Medicine Products: